review article | Q7318358 |
scholarly article | Q13442814 |
P2093 | author name string | Bryan R Haugen | |
P2860 | cites work | Thyrotropin Suppression by Metformin | Q22241662 |
Multicenter phase II study of oral bexarotene for patients with metastatic breast cancer | Q28183171 | ||
The rexinoid LG100754 is a novel RXR:PPARgamma agonist and decreases glucose levels in vivo | Q34084550 | ||
Bexarotene-induced hypothyroidism: bexarotene stimulates the peripheral metabolism of thyroid hormones. | Q34619927 | ||
Metformin reduces thyrotropin levels in obese, diabetic women with primary hypothyroidism on thyroxine replacement therapy | Q34712176 | ||
The role of glucocorticoids in the regulation of thyroid function in man | Q35580875 | ||
Somatostatin receptors in pituitary function, diagnosis and therapy | Q35849430 | ||
TSH-lowering effect of metformin in type 2 diabetic patients: differences between euthyroid, untreated hypothyroid, and euthyroid on L-T4 therapy patients. | Q37319151 | ||
Neuroendocrine control of thyrotropin secretion | Q40085718 | ||
Effects of rexinoids on thyrotrope function and the hypothalamic-pituitary-thyroid axis | Q40348136 | ||
The effect of glucocorticoids on thyrotropin secretion | Q40350962 | ||
Drugs and thyroid function | Q40369794 | ||
Phase 2 and 3 clinical trial of oral bexarotene (Targretin capsules) for the treatment of refractory or persistent early-stage cutaneous T-cell lymphoma. | Q40602894 | ||
Different responses to chronic somatostatin analogues in patients with central hyperthyroidism | Q42473435 | ||
Acute and chronic effects of octreotide on thyroid axis in growth hormone-secreting and clinically non-functioning pituitary adenomas | Q42482059 | ||
Studies on the conditions determining the inhibitory effect of somatostatin on adrenocorticotropin, prolactin and thyrotropin release by cultured rat pituitary cells | Q42494803 | ||
Bromocriptine treatment of prolactin secreting macroadenomas: a radiological, ophthalmological and endocrinological study | Q42525576 | ||
Multi-institutional phase I/II trial of oral bexarotene in combination with cisplatin and vinorelbine in previously untreated patients with advanced non-small-cell lung cancer | Q43607766 | ||
Thyroid hormones in epileptic children receiving carbamazepine and valproic acid | Q43694296 | ||
The novel somatostatin ligand (SOM230) regulates human and rat anterior pituitary hormone secretion | Q43872330 | ||
Mechanism of selective retinoid X receptor agonist-induced hypothyroidism in the rat. | Q44072037 | ||
Kinase-dependent regulation of the secretion of thyrotrophin and luteinizing hormone by glucocorticoids and annexin 1 peptides | Q44581735 | ||
Activation of the Retinoid X Receptor Suppresses Appetite in the Rat | Q44646978 | ||
Effects of rexinoids on glucose transport and insulin-mediated signaling in skeletal muscles of diabetic (db/db) mice | Q44785416 | ||
Pulsatile thyrotropin release and thyroid function in acromegalics before and during subcutaneous octreotide infusion | Q45227162 | ||
Bromocriptine reduces augmented thyrotropin secretion in obese premenopausal women. | Q46135193 | ||
Effect of one year continuous subcutaneous infusion of a somatostatin analogue, octreotide, on early retinopathy, metabolic control and thyroid function in Type I (insulin-dependent) diabetes mellitus | Q46648803 | ||
Imatinib induces hypothyroidism in patients receiving levothyroxine | Q46731246 | ||
Central hypothyroidism with oxcarbazepine therapy | Q46966117 | ||
Dopamine infusion and anterior pituitary gland function in very low birth weight infants. | Q46969201 | ||
The effect of a continuous infusion of a somatostatin analogue (octreotide) for two years on growth hormone secretion and height prediction in tall children | Q47355107 | ||
Dopamine stimulates release of thyrotrophin-releasing hormone from perfused intact rat hypothalamus via hypothalamic D2-receptors | Q48179275 | ||
Efficacy of bromocriptine administration for selective pituitary resistance to thyroid hormone | Q48375739 | ||
The effect of SMS 201-995, a long-acting somatostatin analogue, on anterior pituitary function in healthy male volunteers | Q48420949 | ||
Effects of dopamine and somatostatin on pulsatile pituitary glycoprotein secretion | Q48595323 | ||
Thyrotropin levels during hydrocortisone infusions that mimic fasting-induced cortisol elevations: a clinical research center study. | Q51572999 | ||
Glucocorticoids Decrease Thyrotropin-Releasing Hormone Messenger Ribonucleic Acid Expression in the Paraventricular Nucleus of the Human Hypothalamus | Q57821684 | ||
Evidence for thyrotropin-releasing hormone and glucocorticoid receptor-immunoreactive neurons in various preoptic and hypothalamic nuclei of the male rat | Q67270797 | ||
Effects of carbamazepine on pituitary responsiveness to luteinizing hormone-releasing hormone, thyrotropin-releasing hormone, and metoclopramide in epileptic patients | Q69174393 | ||
The role of glucocorticoids in the regulation of thyrotropin | Q69210371 | ||
Molecular biology of somatostatin receptors | Q70787809 | ||
Dopamine and the sick euthyroid syndrome in critical illness | Q72628788 | ||
Effects of variations in physiological cortisol levels on thyrotropin secretion in subjects with adrenal insufficiency: a clinical research center study | Q73687489 | ||
Central hypothyroidism associated with retinoid X receptor-selective ligands | Q77293298 | ||
Single-dose rexinoid rapidly and specifically suppresses serum thyrotropin in normal subjects | Q79297653 | ||
Thyroid function and volume in epileptic children using carbamazepine, oxcarbazepine and valproate | Q80110527 | ||
P433 | issue | 6 | |
P304 | page(s) | 793-800 | |
P577 | publication date | 2009-12-01 | |
P1433 | published in | Best Practice and Research: Clinical Endocrinology and Metabolism | Q15755890 |
P1476 | title | Drugs that suppress TSH or cause central hypothyroidism | |
P478 | volume | 23 |
Q58124622 | 2018 European Thyroid Association (ETA) Guidelines on the Diagnosis and Management of Central Hypothyroidism |
Q92510934 | A Systematic Review and Meta-Analysis of Patient Preferences for Combination Thyroid Hormone Treatment for Hypothyroidism |
Q37222370 | A clinical review of the association of thyroid stimulating hormone and cognitive impairment |
Q37990792 | A review of the evidence for and against increased mortality in hypothyroidism |
Q48512069 | ACTH-secreting pituitary microadenomas are associated with a higher prevalence of central hypothyroidism compared to other microadenoma types |
Q46326286 | Autoimmune Hypothyroidism As a Predictor of Mortality in Chronic Hypersensitivity Pneumonitis |
Q22306204 | Central Hypothyroidism: Pathogenic, Diagnostic, and Therapeutic Challenges |
Q35205084 | Central hypothyroidism |
Q39332895 | Central hypothyroidism - a neglected thyroid disorder |
Q48085347 | Central hypothyroidism in adults: better understanding for better care |
Q27022818 | Clinical conundrums in management of hypothyroidism in critically ill geriatric patients |
Q47209394 | Clinical course of infants with congenital heart disease who developed thyroid dysfunction within 100 days. |
Q34367086 | Clinical review: The thyroid in mind: cognitive function and low thyrotropin in older people |
Q36546476 | Cocaine decreases expression of neurogranin via alterations in thyroid receptor/retinoid X receptor signaling |
Q33628549 | Congenital hypothyroidism presenting as pseudo-obstruction in preterm infants. |
Q50110157 | Drug interactions in users of tablet vs. oral liquid levothyroxine formulations: a real-world evidence study in primary care |
Q41492126 | Drug interactions with levothyroxine therapy in patients with hypothyroidism: observational study in general practice |
Q41996257 | Effects of forced swimming stress on thyroid function, pituitary thyroid-stimulating hormone and hypothalamus thyrotropin releasing hormone expression in adrenalectomy Wistar rats |
Q27009171 | Endocrinopathies in survivors of childhood neoplasia |
Q38867148 | Endocrinopathies, Bone Health, and Insulin Resistance in Patients with Fanconi Anemia after Hematopoietic Cell Transplantation. |
Q41108953 | Functional correlates of TSH, fT3 and fT4 in Alzheimer disease: a F-18 FDG PET/CT study |
Q64998313 | Hypothalamic-Pituitary-Thyroid Axis Perturbations in Male Mice by CNS-Penetrating Thyromimetics. |
Q28552577 | Hypothyroidism Side Effect in Patients Treated with Sunitinib or Sorafenib: Clinical and Structural Analyses |
Q92432144 | INSUFFICIENCY OF LEVOTHYROXINE THERAPY IN AUTOIMMUNE HYPOTHYROIDISM: EFFECT OF GLUCOCORTICOID ADMINISTRATION |
Q38657238 | In Individuals Following Aneurysmal Subarachnoid Haemorrhage, Hair Cortisol Concentrations Are Higher and More Strongly Associated with Psychological Functioning and Sleep Complaints than in Healthy Controls |
Q57853845 | Interactions between hypothalamic pituitary thyroid axis and other pituitary dysfunctions |
Q38083056 | Laboratory thyroid function testing: do abnormalities always mean pathology? |
Q57853860 | Less known aspects of central hypothyroidism: Part 1 – Acquired etiologies |
Q44177606 | Levothyroxine replacement therapy and refractory hypotension out of transitional period in preterm infants |
Q34373289 | Metformin and low levels of thyroid-stimulating hormone in patients with type 2 diabetes mellitus. |
Q42480377 | Mitotane treatment in patients with adrenocortical cancer causes central hypothyroidism. |
Q48793064 | Morphological and functional changes in pituitary-thyroid axis following prolonged exposure of female rats to constant light. |
Q38213169 | Non-thyroidal illness in the ICU: a syndrome with different faces |
Q89287232 | Octreotide Use in Neonates: A Case Series |
Q37622454 | Perinatal factors associated with neonatal thyroid-stimulating hormone in normal newborns. |
Q37379346 | Pitfalls in the measurement and interpretation of thyroid function tests |
Q24629767 | Polybrominated diphenyl ether (PBDE) flame retardants and thyroid hormone during pregnancy |
Q42961433 | Postprandial changes of amino acid and acylcarnitine concentrations in dried blood samples |
Q97524827 | Preliminary Investigation of Association between Methylphenidate and Serum Growth Markers in Children with Attention-Deficit/Hyperactivity Disorder: A Cross-Sectional Case-Control Study |
Q55471416 | Prevalence of subclinical hypothyroidism in pregnancy in Saudi Arabia. |
Q86040332 | Reversible pituitary insufficiency due to bexarotene therapy in a patient with mycosis fungoides |
Q92189003 | Subclinical Thyroid Dysfunction was not Associated with Cardiac Arrhythmias in a Cross-Sectional Analysis of the ELSA-Brasil Study |
Q86592277 | Subclinical non-autoimmune hypothyroidism in children with steroid resistant nephrotic syndrome |
Q37017262 | TSH - Clinical Aspects of its Use in Determining Thyroid Disease in the Elderly. How Does it Impact the Practice of Medicine in Aging? |
Q36879932 | The Use of TSH in Determining Thyroid Disease: How Does It Impact the Practice of Medicine in Pregnancy? |
Q40147521 | The challenges of treating Ebola virus disease with experimental therapies |
Q48627666 | The effect of metformin on the hypothalamic-pituitary-thyroid axis in women with polycystic ovary syndrome and subclinical hypothyroidism. |
Q89216441 | The forgotten effects of thyrotropin-releasing hormone: Metabolic functions and medical applications |
Q35500038 | Thyroid dysfunction from antineoplastic agents |
Q35142964 | Thyroid hormone regulation by stress and behavioral differences in adult male rats |
Q39427004 | Thyroid testing in acutely ill patients may be an expensive distraction |
Q42487238 | Thyroidal effect of metformin treatment in patients with polycystic ovary syndrome. |
Q34373806 | Thyrotropin isoforms: implications for thyrotropin analysis and clinical practice |
Q44885081 | Thyroxine treatment: absorption, malabsorption, and novel therapeutic approaches. |
Q45917936 | Visuospatial, visuoperceptual, and visuoconstructive abilities in congenital hypothyroidism. |
Search more.